Stock Events

Stock Events

60 Degrees Pharmaceuticals 

$1.87
11
+$0.12+6.86% Wednesday 20:00

Statistics

Day High
1.91
Day Low
1.7
52W High
17.68
52W Low
1.29
Volume
196,043
Avg. Volume
4,569,511
Mkt Cap
7.91M
P/E Ratio
19.43
Dividend Yield
-
Dividend
-

Upcoming

Earnings

14MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-4.65
-3.5
-2.35
-1.21
Expected EPS
-1.88
Actual EPS
N/A

Financials

-1,165.25%Profit Margin
Unprofitable
2022
2023
2024
1.36MRevenue
-15.89MNet Income

Analyst Ratings

$13.40Average Price Target
The highest estimate is 24.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SXTP. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences is a biopharmaceutical company that competes with 60 Degrees Pharmaceuticals in the development and marketing of treatments for infectious diseases, including those in tropical regions.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global pharmaceutical corporation that competes across various therapeutic areas, including infectious diseases, which overlaps with 60 Degrees Pharmaceuticals' focus.
Merck
MRK
Mkt Cap214.76B
Merck & Co. is involved in the discovery, development, manufacturing, and marketing of pharmaceuticals for infectious diseases, directly competing with 60 Degrees Pharmaceuticals.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its pharmaceutical segment Janssen, competes in the area of infectious diseases, offering treatments that could be alternatives to those developed by 60 Degrees Pharmaceuticals.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie competes in the pharmaceuticals market, including infectious diseases, with a strong emphasis on research and development, making it a competitor to 60 Degrees Pharmaceuticals.
Novartis
NVS
Mkt Cap237.61B
Novartis is a global healthcare company that has a broad portfolio, including treatments for infectious diseases, competing with 60 Degrees Pharmaceuticals.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline focuses on pharmaceuticals and vaccines for infectious diseases, directly competing with 60 Degrees Pharmaceuticals in this therapeutic area.
Sanofi
SNY
Mkt Cap124.45B
Sanofi is a global biopharmaceutical company focused on human health, including infectious diseases, making it a competitor to 60 Degrees Pharmaceuticals.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb is a global biopharmaceutical company with a focus on discovering, developing, and delivering innovative medicines, including for infectious diseases, competing with 60 Degrees Pharmaceuticals.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca is a global, science-led biopharmaceutical business that operates in various therapeutic areas, including infectious diseases, making it a competitor to 60 Degrees Pharmaceuticals.

About

60 Degrees Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is based in Washington, District of Columbia.
Show more...
CEO
Dr. Geoffrey Stuart Dow Ph.D.
Employees
3
Country
US
ISIN
US83006G5009

Listings

XNAS
US
SXTP
XNAS
US
SXTPW
BOATS
BOATS
SXTP.BOATS

0 Comments

Share your thoughts

FAQ

What is 60 Degrees Pharmaceuticals stock price today?▼
The current price of SXTP is $1.87 USD — it has increased by +6.86% in the past 24 hours. Watch 60 Degrees Pharmaceuticals stock price performance more closely on the chart.
What is 60 Degrees Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange 60 Degrees Pharmaceuticals stocks are traded under the ticker SXTP.
Is 60 Degrees Pharmaceuticals stock price growing?▼
SXTP stock has risen by +25.5% compared to the previous week, the month change is a -38.49% fall, over the last year 60 Degrees Pharmaceuticals has showed a -75.07% decrease.
What is 60 Degrees Pharmaceuticals market cap?▼
Today 60 Degrees Pharmaceuticals has the market capitalization of 7.91M
When is the next 60 Degrees Pharmaceuticals earnings date?▼
60 Degrees Pharmaceuticals is going to release the next earnings report on May 14, 2026.
What were 60 Degrees Pharmaceuticals earnings last quarter?▼
SXTP earnings for the last quarter are -2.56 USD per share, whereas the estimation was -2.56 USD resulting in a +0% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is 60 Degrees Pharmaceuticals revenue for the last year?▼
60 Degrees Pharmaceuticals revenue for the last year amounts to 1.36M USD.
What is 60 Degrees Pharmaceuticals net income for the last year?▼
SXTP net income for the last year is -15.89M USD.
How many employees does 60 Degrees Pharmaceuticals have?▼
As of April 02, 2026, the company has 3 employees.
In which sector is 60 Degrees Pharmaceuticals located?▼
60 Degrees Pharmaceuticals operates in the Health Care sector.
When did 60 Degrees Pharmaceuticals complete a stock split?▼
The last stock split for 60 Degrees Pharmaceuticals was on January 20, 2026 with a ratio of 1:4.
Where is 60 Degrees Pharmaceuticals headquartered?▼
60 Degrees Pharmaceuticals is headquartered in Washington, US.